November 8, 2019 by Johnson Paul
The latest market report published by Credence Research, Inc. “Osseointegration Implants Market: Growth, Future Prospects, and Competitive Analysis, 2019 – 2027” the osseointegration implants market was valued at US$ 4,126.2Mn in 2018, expected to grow at a CAGR of 7.0% during the forecast period from 2019 to 2027.
The global osseointegration implants market is growing effectually from 2019 to 2027 accredited to the rise in implantation procedures for spinal injuries, lower limb implantations, dental implants and other bone-anchored procedures on a global scale. New launch of products with improved biological solutions, and enhancement in cochlear implants and auditory osseointegrated implants will drive the market growth in the near future. For instance, in September 2017, Integrum AG launched OPRA Implant System Platform G; it improves the mechanical performance of the system, simplify and streamlines the surgery with enhanced osseointegration procedure. Moreover, in Feb 2019, Integrum AG collaborated with The London Clinic and London International Patient Services to offer an innovative osseointegration-based service to above-the-knee and arm amputees in the osseointegration center in the U.K., helped many patients with the OPRA™ Implant System for improving limb function and reducing pain related complications.
Browse the full report at https://www.credenceresearch.com/report/osseointegration-implants-market
Top implant manufacturers are engaged on new product improvement and FDA approval on a global scale. Increasing number of partnerships and collaborations with research institutes and hospitals internationally will drive the market growth in the U.S. and Europe region. For instance in March 2016, Zimmer-Biomet acquired Ortho Transmission, LLC (osseointegrated prosthesis technology for amputees) to further expand its transcutaneous osseous integrated skeletal implant technology in collaboration with the U.S. Department of Defense, in order to restore the mobility of amputee patients.
The U.S. market generated maximum revenue share due to increasing implantation procedures mainly for spinal and dental with combined biological solutions, improved R&D for enhanced biomaterials and a significant pool of patients with hip and knee replacement procedures.
Download Free PDF Sample Request: https://www.credenceresearch.com/sample-request/59996
Key Market Movements:
Report Scope by Segments
By Product Type (2017–2027; US$ Mn)
• Dental Components
o Abutments (Temporary & Definitive)
• Bone-Anchored Prostheses
o Upper Limb
o Lower Limb
• Spinal Implants
By Material Type (2017–2027; US$ Mn)
By End User Segment (2017–2027; US$ Mn)
• Dental Clinics
• Ambulatory Surgical Centers
By Geography Segment (2017–2027; US$ Mn)
• North America (U.S., Rest of North America)
• Europe (U.K., Germany, France, Rest of Europe)
• Asia Pacific (Japan, China, India, Rest of Asia Pacific)
• Rest of the World (Middle East & Africa, Latin America)